New Launch! ⭐ India’s First Ayurvedic Lube | Flat 10% off on Prepaid Orders.  Click here

Close this search box.

Treatment Associated Regrets In Prostate Cancer

Prostate cancer

Prostate cancer is one of the most common cancers in men, and the treatment options for this disease have improved significantly in recent years. However, despite these advances, some men may experience treatment-associated regrets (TARs) after their treatment.

TARs refer to negative feelings that patients experience after treatment, such as regret, disappointment, or a sense of loss. These feelings can be related to various aspects of treatment, such as the choice of treatment, side effects, or the impact of treatment on quality of life.

One study conducted by researchers at the University of California, San Francisco, found that TARs were common among men with prostate cancer. The study involved 328 men who had undergone treatment for prostate cancer and found that 27% of participants experienced TARs.

The study also found that younger men, men with higher levels of education, and men who had undergone surgery were more likely to experience TARs. This suggests that factors such as age and education may play a role in how patients perceive and cope with their treatment.

Another study published in the Journal of Clinical Oncology found that patients who received androgen deprivation therapy (ADT) for prostate cancer were more likely to experience TARs than patients who received other treatments. ADT is a type of hormone therapy that is commonly used to treat prostate cancer.

The study involved 964 patients with prostate cancer, and 16% of participants reported experiencing TARs. Among patients who received ADT, 20% experienced TARs, compared to 14% of patients who received other treatments.

The study also found that patients who experienced TARs were more likely to report lower quality of life and higher levels of anxiety and depression. This highlights the importance of addressing TARs in the management of prostate cancer, as they can have significant implications for patients’ well-being.


In conclusion, TARs are common among men with prostate cancer, and they can have a significant impact on a patient’s quality of life. Factors such as age, education, and treatment type may play a role in the development of TARs. Healthcare providers should be aware of the potential for TARs and work with patients to address their concerns and improve their overall well-being.


Get The Latest Updates

Subscribe To Our Weekly Newsletter

No spam, notifications only about new products, updates.


Your Cart